{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:57:35Z","timestamp":1782320255103,"version":"3.54.5"},"posted":{"date-parts":[[2026,6,22]]},"group-title":"Neuroscience","reference-count":48,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Endocytosis replenishes synaptic vesicle (SV) pools that are required for persistent transmission of chronic pain signals within nociceptive spinal circuits. The nociceptor-specific contribution of SV endocytosis to pain and the therapeutic potential of endocytosis inhibitors are unclear. We identified SV endocytosis in nociceptors as a critical driver of ongoing pain and developed a gene-based strategy to target this mechanism. Nociceptor-specific adeno-associated virus-mediated knockdown of adaptor-associated kinase 1 (AAK1) or dynamin 1 (Dnm1) in dorsal root ganglia Nav1.8-positive neurons inhibited postoperative and neuropathic hypersensitivity without affecting baseline mechanical or thermal sensitivity, locomotion or spontaneous behavior. Electrophysiological recordings from spinal neurons combined with optogenetic activation of nociceptor afferents showed that AAK1 or Dnm1 downregulation blocked the sustained synaptic transmission between nociceptors and dorsal horn neurons by disrupting SV recycling and reducing neurotransmitter release probability. Lipid nanoparticle (LNP)-encapsulated CRISPR\/dCas9-repressor mRNA constructs (dCas9-R) were engineered to achieve sustained and reversible transcriptional and epigenetic repression of\n                  <jats:italic>Aak1<\/jats:italic>\n                  or\n                  <jats:italic>Dnm1<\/jats:italic>\n                  following intrathecal delivery. LNP-mediated gene modulation produced sustained downregulation of\n                  <jats:italic>Aak1<\/jats:italic>\n                  or\n                  <jats:italic>Dnm1<\/jats:italic>\n                  mRNA in sensory neurons and resulted in robust and long-lasting analgesia in preclinical models of postoperative, inflammatory, neuropathic and osteoarthritis pain without impairing acute nociception or locomotor activity. Mechanistically, targeting endocytic machinery disrupted SV recycling at nociceptor terminals, thereby reducing excitatory neurotransmission within spinal pain circuits. Together, these findings establish presynaptic endocytic regulation as a convergent mechanism underlying chronic pain and demonstrate the translational potential of LNP-delivered CRISPR\/dCas9-R as a durable, non-opioid pain therapy that surmounts inherent redundancy of pain signaling mechanisms.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>One Sentence Summary<\/jats:title>\n                  <jats:p>Synaptic vesicle endocytosis in nociceptors is a critical mechanism driving ongoing pain and targeting this process with intrathecal LNP-delivered CRISPR\/dCas9-mediated gene repression produces durable, non-opioid analgesia across multiple chronic pain models.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.06.17.732993","type":"posted-content","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:10:16Z","timestamp":1782184216000},"source":"Crossref","is-referenced-by-count":0,"title":["Targeting Synaptic Vesicle Endocytosis in Nociceptors Provides Sustained Pain Relief"],"prefix":"10.64898","author":[{"given":"Raquel","family":"Tonello","sequence":"first","affiliation":[{"name":"Department of Molecular Pathobiology, College of Dentistry, New York University, New York, USA"},{"name":"Pain Research Center, New York University, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda Pessano","family":"Fialho","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathobiology, College of Dentistry, New York University, New York, USA"},{"name":"Pain Research Center, New York University, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Payne","sequence":"additional","affiliation":[{"name":"Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Damo","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathobiology, College of Dentistry, New York University, New York, USA"},{"name":"Pain Research Center, New York University, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Chieca","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Nassini","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Logu","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy L.","family":"Imlach","sequence":"additional","affiliation":[{"name":"Department of Physiology, Neuroscience Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin W.","family":"Pouton","sequence":"additional","affiliation":[{"name":"Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel W.","family":"Bunnett","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathobiology, College of Dentistry, New York University, New York, USA"},{"name":"Pain Research Center, New York University, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026062409051389000_2026.06.17.732993v1.1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-1229"},{"key":"2026062409051389000_2026.06.17.732993v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2014.09.004"},{"key":"2026062409051389000_2026.06.17.732993v1.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.9.767"},{"key":"2026062409051389000_2026.06.17.732993v1.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7456.15"},{"key":"2026062409051389000_2026.06.17.732993v1.5","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2017.0306"},{"key":"2026062409051389000_2026.06.17.732993v1.6","doi-asserted-by":"crossref","unstructured":"B. Cao , Q. Xu , Y. Shi , R. Zhao , H. Li , J. Zheng , F. Liu , Y. Wan , B. Wei , Pathology of pain and its implications for therapeutic interventions. Signal Transduct Target Ther 9, 155 (2024).","DOI":"10.1038\/s41392-024-01845-w"},{"key":"2026062409051389000_2026.06.17.732993v1.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1706626"},{"key":"2026062409051389000_2026.06.17.732993v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.09.028"},{"key":"2026062409051389000_2026.06.17.732993v1.9","doi-asserted-by":"crossref","unstructured":"A. Latremoliere , C. J. Woolf , Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity. The Journal of Pain 10, (2009\/09\/01).","DOI":"10.1016\/j.jpain.2009.06.012"},{"issue":"6","key":"2026062409051389000_2026.06.17.732993v1.10","first-page":"1355","article-title":"The contribution of endocytosis to sensitization of nociceptors and synaptic transmission in nociceptive circuits","volume":"164","year":"2022","journal-title":"Pain"},{"key":"2026062409051389000_2026.06.17.732993v1.11","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1097\/j.pain.0000000000003657","article-title":"Endophilin A1 and synaptojanin 1-dependent endocytosis of synaptic vesicles in nociceptive spinal circuits maintains postoperative and cancer pain","volume":"166","year":"2025","journal-title":"Pain"},{"key":"2026062409051389000_2026.06.17.732993v1.12","doi-asserted-by":"crossref","unstructured":"Y. Z. Li , R. R. Ji , Gene therapy for chronic pain management. Cell Rep Med 5, 101756 (2024).","DOI":"10.1016\/j.xcrm.2024.101756"},{"key":"2026062409051389000_2026.06.17.732993v1.13","doi-asserted-by":"crossref","unstructured":"S. V. Ovsepian , S. G. Waxman , S. V. Ovsepian , S. G. Waxman , Gene therapy for chronic pain: emerging opportunities in target-rich peripheral nociceptors. Nature Reviews Neuroscience 2023 24:4 24, (2023-01-19).","DOI":"10.1038\/s41583-022-00673-7"},{"key":"2026062409051389000_2026.06.17.732993v1.14","doi-asserted-by":"crossref","unstructured":"S. S. Azeez , R. S. Hamad , B. K. Hamad , M. S. Shekha , P. Bergsten , Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine. Frontiers in Genome Editing 6, (2024 Dec 12).","DOI":"10.3389\/fgeed.2024.1509924"},{"key":"2026062409051389000_2026.06.17.732993v1.15","first-page":"8","article-title":"The next generation of CRISPR\u2013Cas technologies and applications","volume":"20","year":"2019","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"2026062409051389000_2026.06.17.732993v1.16","doi-asserted-by":"crossref","unstructured":"R. Cai , R. Lv , X. Shi , G. Yang , J. Jin , CRISPR\/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation. Int J Mol Sci 24, (2023).","DOI":"10.3390\/ijms241914865"},{"key":"2026062409051389000_2026.06.17.732993v1.17","doi-asserted-by":"crossref","unstructured":"T. T. H. Thi , E. J. A. Suys , J. S. Lee , D. H. Nguyen , K. D. Park , N. P. Truong , Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines (Basel ) 9, (2021).","DOI":"10.3390\/vaccines9040359"},{"key":"2026062409051389000_2026.06.17.732993v1.18","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1517\/17425247.2014.935337","article-title":"Current strategies for DNA therapy based on lipid nanocarriers","volume":"11","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"2026062409051389000_2026.06.17.732993v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-01086-x"},{"key":"2026062409051389000_2026.06.17.732993v1.20","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00916"},{"key":"2026062409051389000_2026.06.17.732993v1.21","doi-asserted-by":"crossref","unstructured":"L. Duan , K. Ouyang , X. Xu , L. Xu , C. Wen , X. Zhou , Z. Qin , Z. Xu , W. Sun , Y. Liang , Nanoparticle Delivery of CRISPR\/Cas9 for Genome Editing. Front Genet 12, 673286 (2021).","DOI":"10.3389\/fgene.2021.673286"},{"key":"2026062409051389000_2026.06.17.732993v1.22","doi-asserted-by":"crossref","unstructured":"M. Antal , Molecular Anatomy of Synaptic and Extrasynaptic Neurotransmission Between Nociceptive Primary Afferents and Spinal Dorsal Horn Neurons. Int J Mol Sci 26, (2025).","DOI":"10.3390\/ijms26052356"},{"key":"2026062409051389000_2026.06.17.732993v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-019-0591-y"},{"key":"2026062409051389000_2026.06.17.732993v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-020-0966-x"},{"key":"2026062409051389000_2026.06.17.732993v1.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0048-5"},{"key":"2026062409051389000_2026.06.17.732993v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.03.025"},{"key":"2026062409051389000_2026.06.17.732993v1.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-020-0669-6"},{"key":"2026062409051389000_2026.06.17.732993v1.28","doi-asserted-by":"crossref","first-page":"e2417097","DOI":"10.1002\/adma.202417097","article-title":"Lipid Nanoparticles Enhance mRNA Delivery to the Central Nervous System Upon Intrathecal Injection","volume":"37","year":"2025","journal-title":"Adv Mater"},{"key":"2026062409051389000_2026.06.17.732993v1.29","doi-asserted-by":"crossref","unstructured":"S. H. Kiaie , N. Majidi Zolbanin , A. Ahmadi , R. Bagherifar , H. Valizadeh , F. Kashanchi , R. Jafari , Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects. J Nanobiotechnology 20, 276 (2022).","DOI":"10.1186\/s12951-022-01478-7"},{"key":"2026062409051389000_2026.06.17.732993v1.30","doi-asserted-by":"crossref","unstructured":"A. M. Moreno , F. Aleman , G. F. Catroli , M. Hunt , M. Hu , A. Dailamy , A. Pla , S. A. Woller , N. Palmer , U. Parekh , D. McDonald , A. J. Roberts , V. Goodwill , I. Dryden , R. F. Hevner , L. Delay , G. Goncalves Dos Santos, T. L. Yaksh , P. Mali , Long-lasting analgesia via targeted in situ repression of Na(V)1.7 in mice. Sci Transl Med 13, (2021).","DOI":"10.1126\/scitranslmed.aay9056"},{"key":"2026062409051389000_2026.06.17.732993v1.31","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1064-19.2019"},{"key":"2026062409051389000_2026.06.17.732993v1.32","doi-asserted-by":"crossref","unstructured":"M. A. Huerta , M. M. Garcia , B. Garcia-Parra , A. Serrano-Afonso , N. Paniagua , Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled Trials. Int J Mol Sci 24, (2023).","DOI":"10.3390\/ijms241612987"},{"key":"2026062409051389000_2026.06.17.732993v1.33","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1021\/acs.jmedchem.1c02131","article-title":"Discovery of (S)-1-((2\u2019,6-Bis(difluoromethyl)-[2,4\u2019-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176\/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic Pain","volume":"65","year":"2022","journal-title":"J Med Chem"},{"key":"2026062409051389000_2026.06.17.732993v1.34","doi-asserted-by":"crossref","unstructured":"J. F. Nabhan , K. M. Wood , V. P. Rao , J. Morin , S. Bhamidipaty , T. P. LaBranche , R. L. Gooch , F. Bozal , C. E. Bulawa , B. C. Guild , Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich\u2019s ataxia. Sci Rep 6, 20019 (2016).","DOI":"10.1038\/srep20019"},{"key":"2026062409051389000_2026.06.17.732993v1.35","doi-asserted-by":"crossref","unstructured":"A. Kristof , K. Karunakaran , C. Allen , P. Mizote , S. Briggs , Z. Jian , P. Nash , J. Blazeck , Engineering novel CRISPRi repressors for highly efficient mammalian gene regulation. Genome Biol 26, 278 (2025).","DOI":"10.1186\/s13059-025-03640-4"},{"key":"2026062409051389000_2026.06.17.732993v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2023.03.013"},{"key":"2026062409051389000_2026.06.17.732993v1.37","doi-asserted-by":"crossref","unstructured":"R. Nassini , M. Chieca , M. Marini , L. Landini , F. De Logu , AAV vectors: an emerging strategy for chronic pain management. Trends Mol Med, (2025).","DOI":"10.1016\/j.molmed.2025.08.008"},{"key":"2026062409051389000_2026.06.17.732993v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.02.014"},{"key":"2026062409051389000_2026.06.17.732993v1.39","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.20.040180.002301"},{"key":"2026062409051389000_2026.06.17.732993v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(94)90144-9"},{"key":"2026062409051389000_2026.06.17.732993v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(88)90026-7"},{"key":"2026062409051389000_2026.06.17.732993v1.42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bph.13652","article-title":"The peptide Phalpha1beta, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice","volume":"174","year":"2017","journal-title":"Br J Pharmacol"},{"key":"2026062409051389000_2026.06.17.732993v1.43","first-page":"1","article-title":"Suppression of neuropathic pain and comorbidities by recurrent cycles of repetitive transcranial direct current motor cortex stimulation in mice","volume":"11","year":"2021","journal-title":"Scientific Reports"},{"key":"2026062409051389000_2026.06.17.732993v1.44","doi-asserted-by":"crossref","unstructured":"T. Pitcher , J. Sousa-Valente , M. Malcangio , The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse. J Vis Exp, (2016).","DOI":"10.3791\/53746-v"},{"key":"2026062409051389000_2026.06.17.732993v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2013.12.010"},{"key":"2026062409051389000_2026.06.17.732993v1.46","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200310000-00041"},{"key":"2026062409051389000_2026.06.17.732993v1.47","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-561-9_15"},{"key":"2026062409051389000_2026.06.17.732993v1.48","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400917"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.17.732993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:05:51Z","timestamp":1782317151000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.06.17.732993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":48,"URL":"https:\/\/doi.org\/10.64898\/2026.06.17.732993","relation":{},"subject":[],"published":{"date-parts":[[2026,6,22]]},"subtype":"preprint"}}